drug

PP6M injection Dose 2

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Janssen, L.P. - Investigator Initiated Studies Program
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
A Study of Paliperidone Palmitate 6-Month Formulation
NCT04072575Phase 3Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Janssen, L.P. - Investigator Initiated Studies Program
company
trial
A Study of Paliperidone Palmitate 6-Month Formulation
PHASE3
trial
indication
Schizophrenia
indication
Schizophrenia
indication